VTS-270: Completed Ph IIb/III enrollment

Vtesse completed enrollment of >51 patients in a double-blind, sham-controlled, international Phase IIb/III trial evaluating lumbar intrathecal infusions of VTS-270 every 2 weeks. The first part will ...